Personalizing Mental Health: Digital Therapeutics Across Life Stages and Populations

April 30 @ 11am – 2pm ET

Share:

RSVP to attend

Speakers

President
Adjunct Professor
Co-Founder & CEO

Director of Life Sciences & Healthcare

Partners

Agenda

11:00 AM

Catalyzing Change: Supporting Women Founders in Health Innovation

Richard Lipkin, Founder, Catalytic Impact Foundation

11:15 AM

Personalizing Mental Health: Digital Therapeutics Across Life Stages and Populations

Neejed Kassam, CEO & Co-Founder, Rewire Digital Therapeutics

11:30 AM

Advancing Women’s Health Innovation: Vision, Leadership, and the Road Ahead

Wayne Cafran, Board of Directors, Emblem Health

11:45 AM

Connecting Communities and Care: Innovation in Women’s Health

Dr. Lisa Fitzpatrick, Entrepreneur, CEO of Grapevine Health

12:00 PM

Predicting the Future of Women’s Health: Personalized Fertility and Menopause Forecasting

Dr. Nicholas Gentry, PhD Co-founder and CEO, Life Ahead

12:10 PM

Investing in the Future of Women’s Health: Innovation and Impact

Julia Monfrini Peev, Managing Partner, PACE Healthcare Capital

12:20 PM

Investment Momentum and Opportunities in Women’s Health

Yvanka de Soysa, Associate, Foreground Capital

12:30 PM

Investing in Women’s Health: What VCs Are Really Looking For in 2026

Tiffany Yu, Principal,  7wire Ventures

12:40 PM

From Articles to Evidence: How HITLAB Helped An Innovative Heart Company Create a World Class Meta-Analysis

Dr. Meghana Helder, CEO & Founder, Octin Health

12:50 PM

HiXConnect: Transforming Healthcare Data and Interoperability

Bhagya Prashanth, Co-Founder & Chief Product Officer, HiXConnect

1:00 PM

Redefining Women’s Health: Innovation and Impact in Clinical Trials

Dr. Harsha K. Rajasimha, CEO and Founder, Jeeva Clinical Trials Inc

1:10 PM

Session

James Fischer, Corporate Partner, DLA Piper

1:20 PM

Driving Impact in Women’s Health: Outcomes Research and Evidence-Based Care

Dr. Kate Stephenson, VP of Engineering, Cern Corporation

Neelima Firth, Advisor in Commercialization Strategy, Cern Corporation

1:35 PM

Revolutionizing Pelvic Health: Digital Rehabilitation Across the Female Life Course

Wendy Powell, Founder & CEO, MUTU System

1:45 PM

Empowering Capital: Women Investors Driving HealthTech Innovation

Lata Setty, Deal Team & Limited Partner Advisory Council, How Women Invest

Want to speak, sponsor, or participate more in our events?

Merck Global Health Innovation

Merck Global Health Innovation Fund (MGHIF) is a growth investor partnering with innovative digital health and data science companies that facilitate and optimize biopharmaceutical operations with the goal of improving patient care.

FINN Partners

FINN Partners is more than an integrated marketing agency. We are smart, passionate communications advocates on a mission to make a difference in the world. We change the way brands relate to their markets. The way companies are positioned and perceived. The way causes become movements. How stakeholders view stakes. How great stories are told and shared to earn attention. Where leads are generated and results tracked. We’ve even changed the way people within an agency collaborate and pull together for the greater good. Our work reflects our values. What we do is how we do things. Whether inside our walls or on the front lines of business transformation and social change, we stand together to create meaningful and measurable impact on the world around us.

Thank you for registering for the event!

We have sent a email confirmation with the Zoom link and add-to-calendar links.

Information Mediary Corp

IMC is the global leader in smart medication adherence solutions, having supplied over a million units to the clinical trials and research markets. IMC manufactures iOS and Android NFC-certified Med-ic Smart Blister Packages, eCAP Smart Medication Bottles and the temperature-aware Med-ic Smart Syringe Pack. IMC is active in the AI-enabled digital health field, offering its HIPAA compliant, secure CertiScan clinical research adherence cloud. IMC’s latest Lilipond AI project is aimed at detecting opiate abuse early to avoid dependence and addiction.